Cis Pt231-Tau Drives Neurodegeneration in Bipolar Disorder Publisher Pubmed



Naserkhaki R¹ ; Zamanzadeh S² ; Baharvand H³ ; Nabavi SM¹ ; Pakdaman H⁴ ; Shahbazi S¹ ; Vosough M⁵ ; Ghaedi G⁶ ; Barzegar A⁷ ; Mirtorabi D⁷ ; Hedayatshodeh M⁸ ; Ehsani E⁹ ; Falahati M¹⁰ ; Hajipour MJ¹¹ Show All Authors Show Affiliations
Source: ACS Chemical Neuroscience Published:2019

Abstract

Bipolar disorder is a complex neuropsychiatric disorder, characterized by intermittent episodes of mania and depression. Recent studies have indicated argyrophilic grains, composed of hyperphosphorylated tau, are observable in postmortem brains of bipolar patients. It remains uncertain how tau hyperphosphorylation results in neurodegeneration upon the disease. Recent studies have demonstrated that phosphorylated tau at Thr231 exists in two distinct cis and trans conformations, in which cis pT231-tau is highly neurotoxic and acts as an early driver of tauopathy in several neurodegenerative diseases. We herein employed an in vitro model, which resembles some aspects of bipolar disorder, to study the cis p-tau mediatory role. We established GSK3β overexpressing SH-SY5Y cells and examined cell viability, cis p-tau formation, and lithium effects by immunofluorescence and flow cytometry. We found an increase in cis p-tau levels as well as viability decrease in the cell model. Furthermore, we discovered that lithium treatment inhibits cis p-tau formation, resulting in diminished cell death. We also examined BD and healthy human brain samples and detected cis p-tau in the patients' brains. Our results show that tauopathy, observed in bipolar disorder, is being mediated through cis p-tau and that a conformer could be the cause of neurodegeneration upon the disease. Our findings would suggest novel therapeutic target to fight the devastating disorder. © 2019 American Chemical Society.